Vipul Bhrigu

Molecular scientist Vipul Bhrigu began his post-secondary education and training at the University of Rajasthan in Jaipur, India, where he studied zoology, chemistry, and biotechnology and earned his Bachelor of Science. He next attended Bangalore University, where he received a Master of Science in Biotechnology. Vipul Bhrigu traveled to the United States to study in The University of Toledo’s Biomedical Sciences Program, where he focused on cancer research for seven years, completing in-depth research in the areas of mammalian cell culture, gene expression, and virology. Vipul Bhrigu’s primary research project, “Replication of Adeno-Associated Virus (AAV) in Murine Fibroblasts with Mouse Adenovirus Provided Helper Functions,” appeared in the July 2009 issue of Virology. Vipul Bhrigu co-authored “AAV and Adenovirus Coinfection Induces Cellular DNA Damage Responses via Redundant P13K Pathways,” which was published in the September 2009 issue of Virology. AAV is a benign virus that is often used by scientists such as Bhrigu to study gene-therapy options for diseases such as cystic fibrosis and Parkinson’s. In addition to publishing his findings, Vipul Bhrigu has spoken at numerous conferences and forums. He presented “Emerging Tools in Molecular Diagnosis” at a conference at Punjab University in India. After earning his Ph.D. in Biomedical Sciences from The University of Toledo, Bhrigu accepted a position as a Postdoctoral Fellow at the University of Michigan, where he researched tumorigenesis. Following his fellowship, Vipul Bhrigu relocated to his native country of India, where he currently lives.